What ATMP Consulting Group does

ATMP Consulting Group is a privately held, founder-led boutique consultancy founded in 2025 and headquartered in Gainesville, Florida, that delivers expert advisory services to organizations developing cell and gene therapies, biologics, and vaccines. Its core offerings span CMC Leadership and Strategy, Manufacturing and CDMO Oversight, Technical Diligence, Product and Process Development across in vivo and ex vivo platforms (AAV, Adenovirus, Lentivirus, Retrovirus, and oncolytic viruses), and Facility Design and Oversight, with regulatory support from Interact and Pre-IND through IND, BLA, and MAA filings in the US, EU, and international markets.

The firm operates a consortium model that aggregates subject matter experts across CMC, Quality, Non-clinical, Regulatory, and Analytical disciplines, enabling multi-discipline engagements without the client coordinating multiple vendors. Its founding team, led by Scott Cross (Founder and CEO, formerly Head of Gene Therapy CMC at Dark Horse Consulting Group), includes Katie Miller (Sr. Principal, 30+ years industry, 15+ years in CGT, previously VP/Head of Quality at Sonoma Biotherapeutics and VP/Global Head of Analytics at Bayer) and Malachi Wickman (Principal Consultant, 8 years CGT experience from American Red Cross Cell & Gene Therapy Solutions and Dark Horse Consulting Group). The company has also formed a strategic alliance with PQP Group, extending its capabilities into UK and EU regulatory licensing, QP release, secondary packaging, and depot/logistics services for advanced therapy products.

Revenue is generated through professional services consulting engagements sold on a sales-led and enterprise field sales basis, with a free consultation offered as the entry point. No pricing, contract values, or revenue figures are publicly disclosed, and no funding rounds or external institutional investment are recorded. Marketing relies on the firm website and LinkedIn presence, and the firm serves enterprise clients primarily across North America, the UK, and the EU.

Name

ATMP Consulting Group

Legal name

ATMP Consulting Group

Website

https://atmpconsult.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

ATMP Consulting Group is a Gainesville, Florida-based boutique consultancy founded in 2025 that provides CMC, manufacturing, regulatory, and facility design advisory services to cell and gene therapy, biologics, and vaccine developers through a consortium of senior SMEs and a strategic alliance with PQP Group.

Ownership category

akta.pro rank

Product category

Biopharmaceutical Consulting

NAICS

Management, Scientific, and Technical Consulting Services (5416), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

akta.pro secondary industry

Gene Therapy Regulatory, Pharmacovigilance & Clinical Operations Services (HLAAACAM)

Keywords

• Cell gene therapy consulting
• CMC strategy consulting
• CDMO oversight services
• Biopharmaceutical regulatory consulting
• Advanced therapy manufacturing consulting

Headquarters

HQ city

Gainesville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations

Revenue model

1. Consulting Services: Expert strategic and technical guidance across advanced therapies, biologics, vaccines and peripheral industries. Services address CMC, manufacturing, analytical and regulatory challenges from early development through commercialization.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

ATMP Consulting Group provides expert consulting services across the cell and gene therapy lifecycle, including CMC leadership and strategy, manufacturing and CDMO oversight, technical diligence, product and process development, and facility design. The firm delivers these services through a consortium model that connects clients with subject matter experts across CMC, Quality, Non-clinical, Regulatory, and Analytical disciplines, supporting advanced therapy sponsors from early development through commercialization.

Product overview

ATMP Consulting Group offers a suite of consulting services for the cell and gene therapy industry. The core offerings include CMC Leadership and Strategy, Manufacturing and CDMO Oversight, Technical Diligence, Product and Process Development, and Facility Design and Oversight. These services are delivered through a consortium model that enables subject matter experts to collaborate across disciplines including CMC, Quality, Non-clinical, Regulatory, and Analytical areas. The company also operates through a strategic alliance with PQP Group to expand global quality leadership and operational capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• CMC Leadership and Strategy

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• PQP GroupcoreStrategic or Co-development Partner · 1 January 2025Strategic alliance combining PQP Group's global quality leadership and operational experience with ATMP Consulting Group's deep hands-on expertise across the cell and gene therapy lifecycle. The alliance enables clients to access a unified network of subject matter experts with combined capabilities supporting both US and EU regulatory strategy, CMC authorship, technical, Quality and supply chain solutions for clinical and commercial programs. PQP Group brings licensed operations across the UK and EU including import, secondary packaging, QP release and depot and logistic services for advanced therapy products.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• PharmaLex: Global regulatory and CMC consulting firm serving pharma and biotech (now part of Cencora). Comparable to ATMP in regulatory strategy and CMC authoring across development phases, but with a far broader therapeutic footprint than ATMP's CGT specialization.
• CRB Group: Engineering, architecture, and consulting firm specializing in life sciences facility design and construction. Directly comparable to ATMP's facility design and oversight offering for advanced therapy manufacturing facilities, though broader in client base.
• ProPharma Group: Life sciences consulting firm providing regulatory, compliance, clinical, and quality services across pharma and biotech. Overlaps with ATMP in regulatory strategy and quality/CMC consulting but is broader in therapeutic and service scope.
• Pharmatech Associates: Consulting firm providing GxP compliance, validation, and engineering services to pharma/biotech manufacturers. Comparable to ATMP's facility design/oversight and CDMO oversight offerings, particularly for build-out and qualification projects.
• Latham BioPharm Group: Life sciences consulting practice serving biotech and pharma across CMC, regulatory, and commercial strategy. Comparable to ATMP in CMC and regulatory advisory but operates as a broader management consultancy rather than a CGT specialist.

Direct peers

• PQP Group: UK/EU-based consulting firm specializing in quality, compliance, and risk-management solutions for pharma, biotech, and cell/gene therapy organizations. Strategic alliance partner of ATMP Consulting Group with overlapping service scope but distinct geographic core.
• Dark Horse Consulting Group: The leading dedicated cell and gene therapy consulting firm; ATMP's founder Scott Cross previously served there as Head of Gene Therapy CMC and Senior Principal. Directly comparable across CMC, manufacturing oversight, regulatory, and facility design services for CGT sponsors.
• Biologic Consulting: Biotech consulting firm offering CMC, regulatory, and quality services to cell, gene, and biologic therapy developers. Closely comparable niche peer to ATMP's CGT-focused service portfolio.
• BioProcess Technology Consultants (BPTC): Consulting firm specializing in bioprocess development, manufacturing, and CMC strategy for biologics and advanced therapies. Directly comparable to ATMP's product/process development, CMC, and CDMO oversight service lines.

Emerging players

• GXP-Compliance: Life sciences consulting firm providing quality assurance, regulatory, and compliance services to pharma and biotech. Comparable to ATMP in regulatory and quality consulting for biologics and CGT developers, with similar boutique scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/atmp-consulting-group

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ATMP Consulting Group